HYDERABAD, India--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today the opening of its new 5,000 square meter (50,000 sq. ft.) research and development centre at the Shapoorji Pallonji Biotech Park in Hyderabad, India.
The new R&D centre, located near AMRI’s existing chemistry facilities in Hyderabad in the ICICI Knowledge Park, will provide additional space for AMRI’s laboratory-scale Indian operations. The new facility includes laboratories for conducting early stage research such as custom chemical synthesis and analytical chemistry. Additional scale up laboratories for preparing both preclinical and clinical trial supply active ingredients are expected to open later this year and 2008, respectively. Those larger laboratories will be used to develop efficient methods to produce active pharmaceutical ingredients and intermediates. The new facility also is equipped with extensive environmental controls and a state-of-the-art wastewater treatment unit. AMRI has invested approximately U.S. $8 million in construction and equipment.
